Glucocorticoid treatment and cardiovascular disease

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Disorders

Background:

• Glucocorticoids are widely used for their anti-inflammatory and immunosuppressive properties.
• Known side effects include hyperglycemia, hypertension, dyslipidemia, and central obesity, contributing to cardiovascular disease.
• The potential link between glucocorticoid use and heart failure remains an area of active investigation.

Discussion:

• This review examines the physiological mechanisms by which glucocorticoids may impact cardiac function.
• It explores the association between glucocorticoid-induced metabolic changes and the exacerbation of heart failure.
• The role of glucocorticoid receptor signaling in cardiac remodeling and dysfunction is discussed.

Key Insights:

• Glucocorticoid-induced metabolic derangements are significant risk factors for cardiovascular events.
• Emerging evidence suggests a direct or indirect contribution of glucocorticoids to the pathophysiology of heart failure.
• Physicians should consider cardiac monitoring in patients on long-term glucocorticoid therapy.

Outlook:

• Further research is needed to elucidate the precise mechanisms linking glucocorticoids to heart failure.
• Clinical trials are warranted to evaluate the efficacy of interventions aimed at mitigating glucocorticoid-induced cardiac toxicity.
• Long-term cardiovascular risk assessment in patients using glucocorticoids should incorporate heart failure evaluation.